COVID-19 Pneumonia
Conditions
Keywords
Breathing Exercise, COVID-19, manual diaphragmatic release, Pulmonary function parameters
Brief summary
Manual noninvasive respiratory techniques gained interest to treat respiratory pathologies related to COVID 19. This study designed to determine the combined effect of manual diaphragmatic release technique with the effect of conventional breathing exercises and prone positioning on pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).
Detailed description
Forty females were randomly assigned to two groups. Group A received manual diaphragm release with conventional breathing exercises and prone positioning. Group B received conventional breathing exercises and prone positioning. Both groups took their prescribed medications. Their ages ranged from 35 to 45 years and with moderate COVID-19 illness. Any cases with mild and severe COVID-19 illness, ICU admission, and chest diseases were excluded. Main measures: pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).
Interventions
OTHERmanual therapy
manual diaphragmatic release technique combined with breathing exercise
OTHERbreathing exercise and prone position alone
deep breathing exercise and prone position
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)
Intervention model description
Forty females were randomly assigned to two groups. Group A received manual diaphragm release with conventional breathing exercises and prone positioning. Group B received conventional breathing exercises and prone positioning. Both groups took their prescribed medications. Their ages ranged from 35 to 45 years and with moderate COVID-19 illness. Any cases with mild and severe COVID-19 illness, ICU admission, and chest diseases were excluded.
Eligibility
Sex/Gender
FEMALE
Age
35 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* women with moderate COVID-19 illness diagnosed by a physician. * Patients with o2 saturation \>94%Nonsmoker subjects. * age ranging from 35-45 years. * body mass index from 25 to 34 kg/m2.
Exclusion criteria
* Unstable hemodynamic status. * Acute respiratory failure requiring intubation and impaired consciousness. * Inability to collaborate with prone positioning with refusal. * Change of mental status hindering response to instructions. * Poorly controlled hypertension (Mean systolic BP \> 140 mmhg and \\or diastolic BP \> 40 mmhg). * Patients who take continuous o2 supplementation. * Smoking. * Other chest diseases as (COPD-asthma-tuberculosis-cancer). * Male patients.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| forced vital capacity FVC | pre study and 3 weeks post study for all participants | the amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible which is a common breathing test to check lung function. |
| FEV1 | pre study and 3 weeks post study for all participants | the maximum amount of air that the subject can forcibly expel during the first second following maximal inhalation |
| PEF | pre study and 3 weeks post study for all participants | show the amount and rate of air that can be forcefully breathed out of the lungs. |
| FEV1/FVC | pre study and 3 weeks post study for all participants | FEV1/FVC, also known as FEV1%) can help distinguish obstructive and restrictive lung diseases. |
| PEF25% | pre study and 3 weeks post study for all participants | Peak expiratory flow at 25% of fvc and the most sensitive measure of airflow in peripheral airways where primary airflow obstruction originates. |
| PEF50% | pre study and 3 weeks post study for all participants | Peak expiratory flow at 50% ofFVC |
| PEF 75% | pre study and 3 weeks post study for all participants | Peak expiratory flow at 75% of FVC |
| PEF 25%/75% | pre study and 3 weeks post study for all participants | Maximum flow rate in the middle 50% of forced expiration. |
Countries
Egypt
Outcome results
None listed